References
Edward RG, Steptoe P, Purdy JM: Establishing full term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 1980;87:737–756
Quigley MM, Schmidt CL, Beauchamp PJ, Pace-Owens S, Wolf DP: Menopausal gonadotropins compared with clomiphene citrate for enhanced follicular recruitment in an vitro fertilization program. Fertil Steril 1984;41:425 (abstr 97)
Beauchamp PJ: Human menopausal gonadotropin for follicular recruitment in in vitro fertilization and embryo transfer.In Human in vitro Fertilization and Embryo Transfer, DP Wolf, MM Quigley (eds). New York, Plenum Press, 1984, p 99
Sato F, Marrs RP: Effect of ovarian hyperstimulation on chromosome aberration and sister chromatid exchange in in vitro fertilization. Fertil Steril 1984;41:245
Sato F, Marrs RP: Effect of ovarian hyperstimulation on chromosome aberration and sister chromatid exchange on in vivo fertilized oocytes. Fertil Steril 1984;41:605
Garcia JE, Jones GS, Acosta AA, Wright G: Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase I, 1981. Fertil Steril 1983;39:167–173
Jones HW, Jr, Jones GS, Andrews MC, Acosta AA, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14–21
Laufer N, DeCherney AH, Haseltine FP, Polan ML, Mezer HC, Dlugi AM, Sweeney D, Nero F, Naftolin F: The use of high-dose human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril 1983;40:734–741
Ben-Rafael Z, Benadiva CA, Ausmanas M, Barber B, Blasco L, Flickinger GL, Mastroianni L: Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril 1987;48:964–968
Ben-Rafael Z, Strauss JF, Mastroianni L, Flickinger GL: Differences in ovarian stimulation in human menopausal gonadotropin treated women may be related to folliclestimulating hormone accumulation. Fertil Steril 1986;46:586–592
Benadiva CA, Ben-Rafael Z, Strauss JF, Mastroianni L, Flickinger GL: Ovarian response of individuals to different doses of human menopausal gonadotropin. Fertil Steril 1988;49:997–1001
Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynecol 1985;92:385–393
Howles CM, MacNamee MC, Edwards RG, Goswamy R, Steptoe PC: Effect of high tonic levels of luteinizing hormone on outcome of in-vitro fertilization. Lancet 1986;2:521–523
Sherizly I, Galiani D, Dekel N: Regulation of oocyte maturation communication in the rat cumulus-oocyte complex. Hum Reprod 1988;3:761–766
O'Neill C, Gidley-Baird AA, Pike IL, Saunders DM: Use of a bioassay for embryo-derived platelet-activating factor as a means of assessing quality and pregnancy potential of human embryos. Fertil Steril 1987;47:969–975
Pantos C, Thornton SJ, Speirs AL, Johnston I: Increasing the human menopausal gonadotropin dose—Does the response really improve? Fertil Steril 1990;53:436–439
van Hooff MHA, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA: Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: A randomized study. Hum Reprod 1993;8:369–373
Jones HW, Acosta AA, Andrews MC, Garcia JE, Jones GS, Mayer J, McDowell JS, Rosenwaks Z, Sandow BA, Veeck LL, Wilkes CA: Three years of in vitro fertilization at Norfolk. Fertil Steril 1984;42:826–834
Bernadus RE, Jones GS, Acosta AA, Garcia JE, Liu HC, Jones DL, Rosenwaks Z: The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth. Fertil Steril 1985;43: 373–378
Muasher SJ, Garcia JE, Rosenwaks Z: The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. Fertil Steril 1985;44:62–69
Benadiva CA, Ben-Rafael Z, Blasco L, Tureck R, Mastroianni L, Flickinger GL: An increased initial follicle-stimulating hormone/luteinizing hormone ratio does not affect ovarian responses and the outcome of in vitro fertilization. Fertil Steril 1988;50:777–781
Quigley MM, Collins RL, Blankstein J: Pure follicle stimulating hormone does not enhance follicular recruitment in clomiphene citrate/gonadotropin combination. Fertil Steril 1988;50:562–566
Lavy G, Pellicer A, Diamond MP, DeCherney AH: Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: A randomized prospective study. Fertil Steril 1988;50:74–78
Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307
Muasher SJ: Stimulation protocols for patients with atypical response. Ann NY Acad Sci 1988;541:82–95
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, T., Ben-Rafael, Z. Low-versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program. J Assist Reprod Genet 12, 235–238 (1995). https://doi.org/10.1007/BF02212924
Issue Date:
DOI: https://doi.org/10.1007/BF02212924